Evaluation of BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to first-line drugs in China
- PMID: 25248118
- PMCID: PMC4172428
- DOI: 10.1371/journal.pone.0099659
Evaluation of BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to first-line drugs in China
Abstract
Background: The purpose of this study was to evaluate the performance of the BACTEC MGIT 960 (M960) system compared with the proportion method (PM) on Löwenstein-Jensen (L-J) medium in a peripheral laboratory in China for the testing of Mycobacterium tuberculosis (MTB) susceptibility to streptomycin (SM), isoniazid (INH) rifampicin (RIF) and ethambutol (EMB) a combination known as SIRE.
Methods: The susceptibility of 205 clinical isolates of MTB to SM, INH, RIF and EMB was performed with the M960 system. The drugs were tested at the following concentrations: 1.0 µg/ml for SM, 0.1 µg/ml for INH, 1.0 µg/ml for RIF, and 5.0 µg/ml for EMB. The results were compared with those obtained by the L-J PM. The L-J PM at an arbiter site was used to resolve any discordant results.
Results: The overall consistency was 96.6% and concordance values were 95.6% for SM, 97.6% for INH, 98.0% for RIF and 95.1% for EMB. The overall sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of the M960 system for PM (the standard method) was 95.6%, 97.3%, 96.2% and 96.9% respectively, and the sensitivity were 93.3% for SM, 96.9% for INH, 97.4% for RIF and 94.6% for EMB, the specificity were 96.9% for SM, 98.2% for INH, 98.4% for RIF and 95.5% for EMB, the PPV were 94.6% for SM, 97.9% for INH, 97.4% for RIF and 94.6% for EMB, the NPV were 96.2% for SM, 97.3% for INH, 98.4% for RIF and 95.5% for EMB. The turnaround time with the M960 system (median 8.0 days, ranged from 5 to 14 days) was significantly shorter than that with the PM (28 days or 42 days).
Conclusion: There was a substantial degree of agreement between the two methods. The M960 system was a reliable and rapid method for SIRE susceptibility testing of tuberculosis in China.
Conflict of interest statement
Similar articles
-
Accuracy of a reverse dot blot hybridization assay for simultaneous detection of the resistance of four anti-tuberculosis drugs in Mycobacterium tuberculosis isolated from China.Infect Dis Poverty. 2020 Apr 16;9(1):38. doi: 10.1186/s40249-020-00652-z. Infect Dis Poverty. 2020. PMID: 32299480 Free PMC article.
-
Multicentre evaluation of an automated BACTEC 960 system for susceptibility testing of Mycobacterium tuberculosis.Int J Tuberc Lung Dis. 2007 Sep;11(9):986-91. Int J Tuberc Lung Dis. 2007. PMID: 17705976
-
Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampin, and ethambutol and comparison with the radiometric BACTEC 460TB method.J Clin Microbiol. 2004 Mar;42(3):1109-14. doi: 10.1128/JCM.42.3.1109-1114.2004. J Clin Microbiol. 2004. PMID: 15004061 Free PMC article.
-
Isoniazid resistance in Rifampicin sensitive pulmonary tuberculosis in children and adolescents.Indian J Tuberc. 2024;71 Suppl 1:S145-S148. doi: 10.1016/j.ijtb.2024.05.002. Epub 2024 May 9. Indian J Tuberc. 2024. PMID: 39067947 Review.
-
Proficiency testing for drug susceptibility testing of Mycobacterium tuberculosis complex using commercial broth microdilution plate in China in 2021.J Glob Antimicrob Resist. 2024 Mar;36:230-236. doi: 10.1016/j.jgar.2023.11.012. Epub 2023 Dec 10. J Glob Antimicrob Resist. 2024. PMID: 38072239 Review.
Cited by
-
Clinical Validation of the QMAC-DST System for Testing the Drug Susceptibility of Mycobacterium tuberculosis to First- and Second-Line Drugs.Front Microbiol. 2019 Apr 16;10:706. doi: 10.3389/fmicb.2019.00706. eCollection 2019. Front Microbiol. 2019. PMID: 31057494 Free PMC article.
-
Rapid Detection of Mycobacterium tuberculosis Strains Resistant to Isoniazid and/or Rifampicin: Standardization of Multiplex Polymerase Chain Reaction Analysis.Am J Trop Med Hyg. 2016 Dec 7;95(6):1257-1264. doi: 10.4269/ajtmh.16-0120. Epub 2016 Oct 24. Am J Trop Med Hyg. 2016. PMID: 27928076 Free PMC article.
-
Molecular characterization and drug resistance patterns of Mycobacterium tuberculosis complex in extrapulmonary tuberculosis patients in Addis Ababa, Ethiopia.PLoS One. 2020 Dec 7;15(12):e0243493. doi: 10.1371/journal.pone.0243493. eCollection 2020. PLoS One. 2020. PMID: 33284842 Free PMC article.
-
Drug resistance characteristics of Mycobacterium tuberculosis isolates between 2014 and 2017 in Sichuan, China: A retrospective study.PLoS One. 2018 Dec 31;13(12):e0209902. doi: 10.1371/journal.pone.0209902. eCollection 2018. PLoS One. 2018. PMID: 30596768 Free PMC article. Clinical Trial.
-
Performance of WHO-Endorsed Rapid Tests for Detection of Susceptibility to First-Line Drugs in Patients with Pulmonary Tuberculosis in Bangladesh.Diagnostics (Basel). 2022 Feb 5;12(2):410. doi: 10.3390/diagnostics12020410. Diagnostics (Basel). 2022. PMID: 35204501 Free PMC article.
References
-
- World Health Organization (2010) Global tuberculosis control: WHO report 2010.WHO/HTM/TB/2010.7.
-
- World Health Organization (2012): Global Tuberculosis Report 2012, Geneva: WHO, WHO/HTM/TB/2012.6.
-
- Nathanson E, Nunn P, Uplekar M, Floyd K, Jaramillo E, et al. (2010) MDR tuberculosis-critical steps for prevention and control. N Engl J Med 363(11): 1050–1058. - PubMed
-
- Zhao Y, Xu S, Wang L, Chin DP, Wang S, et al. (2012) National survey of drug-resistant tuberculosis in China. N Engl J Med 366(23): 2161–2170. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases